Detalles de la búsqueda
1.
Human plasma-derived alpha1 -proteinase inhibitor in patients with new-onset type 1 diabetes mellitus: A randomized, placebo-controlled proof-of-concept study.
Pediatr Diabetes
; 22(2): 192-201, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33244872
2.
A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
Pediatr Diabetes
; 19(5): 1007-1013, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29512902
3.
Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Horm Res Paediatr
; 83(4): 268-79, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25765099
4.
Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
Clin Ther
; 32(12): 2036-47, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21118739
Resultados
1 -
4
de 4
1
Próxima >
>>